Form 4: NeuroMetrix Director Nancy Katz Reports Stock Vesting

Director Nancy Katz reports the vesting of restricted stock units into 5,396 shares of NeuroMetrix common stock on April 30, 2024.

Summary

• On April 30, 2024, Nancy Katz, a director of NeuroMetrix, Inc., had 5,396 restricted stock units vest.
• These units converted into 5,396 shares of common stock at a price of $4.37.
• Following the transaction, Katz directly owns 7,602 shares of NeuroMetrix common stock.
• The restricted stock units were granted on August 4, 2023, and vested fully on April 30, 2024.
• The original grant was for 43,165 restricted stock units, but this was adjusted due to a 1-for-8 reverse stock split effective November 21, 2023.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock vesting, which is neither particularly positive nor negative. It's a neutral event in the normal course of business.

Positives

• The vesting of restricted stock units indicates that the director has met certain performance or time-based milestones set by the company.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted equity compensation.

Stakeholder Impact

• The vesting of stock options can have a minor dilutive effect on existing shareholders.

Key Dates

Keywords

NeuroMetrix, Director, Stock Vesting, Restricted Stock Units, Form 4, Nancy Katz, NURO